How does the current trend toward big data affect HIV? Jeffrey Crowley, a Distinguished Scholar and Program Director of the National HIV/AIDS Initiative at Georgetown Law, describes a new way of thinking about the competing impulses to protect privacy while sharing information that could lead to innovations in care. He examines existing privacy protections, explores how testing and counseling methods have shifted and how big data is impacting HIV treatment and prevention.
Every once in awhile, we work on a project that touches our soul. Such is the case of HIV/SIDA, a four-part series that brought us in contact with people whose paths we otherwise would not have crossed.
In the two years of field reporting, we saw many acts of kindness — the glamorous physician who washes the feet of Tijuana’s poor, the compassionate medical student who worries about a sex worker’s UTI, the transgender woman who overcomes her fear of mockery and reveals her HIV status, the ex-heroin addict who walks the Tijuana River Canal, urging residents to protect themselves by using clean needles, and the Tijuana cop who is teaching his fellow police officers to see addiction as a sickness, not a crime. These are among many featured in this series HIV/SIDA: The Epidemic in Tijuana.
We’ll show you what UC San Diego researchers and others are doing to stop the spread of HIV and how those most affected by the epidemic are coping under difficult conditions. And, we’ll share some of our favorite moments of empathy, moments of hope for humanity, the kind that stick with you, long after the reporting is done.
Submitted by Shannon Bradley, UCTV Producer of HIV/SIDA: The Epidemic in Tijuana
AIDS is one of the most devastating infectious diseases in human history, and its cause, HIV, has been responsible for millions of infections. Every 9.5 minutes, someone in the U.S. is infected with HIV. It is estimated that there are over 56,000 new cases of HIV in the U.S. each year.
Dr. Susan Little of UC San Diego School of Medicine sheds some light on this disease and the possibility of preventing its spread. Her research tracks HIV infection by rapidly obtaining genetic information from those engaged in HIV healthcare. A discussion follows on privacy protections, the risks associated with the use of these data and their potential to significantly limit HIV transmission in communities. Dr. Little is presented by the Center for Ethics in Science and Technology in San Diego.
Browse more programs from the Exploring Ethics Series.
HIV: Past, Present, & Future is the latest series from UCSF Osher Mini Medical School.
In this episode, HIV: Dare We Say Cure?, learn more about HIV treatment and the exciting potential for a cure in the near future. Dr. Peter Hunt breaks down the immunology of the disease, while Dr. Steven Deeks scrutinizes the possibility of achieving a cure for HIV in the near future. Watch as he explain case studies, including the Berlin Patient and the VISCONTI cohort, to determine how close we really are to developing a cure.
Taught by UCSF’s national and international leaders in HIV research, HIV: Past, Present, & Future presents the history of HIV/AIDS, how it was discovered, and how the epidemic continues to evolve worldwide. Watch all of the programs to gain a comprehensive, up-to-the-moment understanding of this complex disease and get a glimpse of what the future holds for a potential cure.
Be sure to check out other programs in the UCSF Osher Mini Medical School series!
Humans have faced many epidemics, from the historical bubonic plague to diseases such as Malaria and Measles that still kill people today. But, none are quite like the virus that runs rampant through modern society: Human Immunodeficiency Virus, HIV.
Dr. Jay Levyan, a professor and AIDS and cancer researcher at UCSF, was one of the doctors involved in the discovery of the disease in the early 1980’s. In “HIV: A Primer,” Dr. Levyan explains some of the basic science behind the disease and what he thinks makes it so different from other epidemics. He says that HIV can interact with and infect a variety of different cells. Our vaccines are formulated to combat the free virus in the body, where medicines to combat HIV need to focus on treating the infected cell.
Dr. C. Bradley Hare, Associate Professor of Clinical Medicine and Medical Director, UCSF HIV/AIDS Division at San Francisco General Hospital gives a more personal look at HIV by examining individual cases of the disease in this most recent video of the HIV: Past, Present, and Future series, presented by UCSF Osher Mini Medical School.
Now that you’ve learned about the history of HIV, see what you know about the prevention of HIV and the future of the disease in this video, “HIV, Prevention and Global Health.”